Swiss Paraplegic Research, Nottwil
spf.chTotal trials
70
Active
11
Phase 3
1
Total enrollment
3,208
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Polyhexanide | — | — | — | — | — | 1 | |
| Mupirocin and Chlorhexidine | — | — | — | — | — | 1 |
Next readouts
- 2027-03-30
Top conditions
- Spinal Cord Injury21
- Spinal Cord Injuries18
- Neurogenic Lower Urinary Tract Dysfunction4
- Chronic Pain2
- Athletes2
- Dietary Supplements2
- Physical Education and Training/Methods2
- Spinal Cord Injuries (SCI)2
Frequently asked questions about Swiss Paraplegic Research, Nottwil
- How many clinical trials does Swiss Paraplegic Research, Nottwil have on ClinicalTrials.gov?
- Swiss Paraplegic Research, Nottwil is listed as the lead sponsor on 70 clinical trials in ClinicalTrials.gov, 11 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Swiss Paraplegic Research, Nottwil's trials are in Phase 3?
- 1 of Swiss Paraplegic Research, Nottwil's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Swiss Paraplegic Research, Nottwil focus on?
- Swiss Paraplegic Research, Nottwil's most-studied conditions on ClinicalTrials.gov are Spinal Cord Injury, Spinal Cord Injuries, Neurogenic Lower Urinary Tract Dysfunction, Chronic Pain, Athletes.
- When are Swiss Paraplegic Research, Nottwil's next clinical trial readouts?
- Swiss Paraplegic Research, Nottwil has 1 upcoming primary-completion readout tracked here; the soonest is “Decolonization Efficacy of Polyhexanide vs. Mupirocin”, expected around 2027-03-30.